Terms: = Liver cancer AND STK11, LKB1, 6794, ENSG00000118046, Q15831, PJS AND Prognosis
50 results:
1. [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].
Wang WN; Liu XT; Liang YM
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
[No Abstract] [Full Text] [Related]
2. Josephin domain containing 2 (JOSD2) promotes lung cancer by inhibiting lkb1 (liver kinase B1) activity.
Yuan T; Zeng C; Liu J; Zhao C; Ge F; Li Y; Qian M; Du J; Wang W; Li Y; Liu Y; Dai X; Zhou J; Chen X; Ma S; Zhu H; He Q; Yang B
Signal Transduct Target Ther; 2024 Jan; 9(1):11. PubMed ID: 38177135
[TBL] [Abstract] [Full Text] [Related]
3. Development of a prognostic model based on anoikis-related genes for predicting clinical prognosis and immunotherapy of hepatocellular carcinoma.
Pang M; Sun X; He T; Liang H; Yang H; Chen J
Aging (Albany NY); 2023 Oct; 15(19):10253-10271. PubMed ID: 37787988
[TBL] [Abstract] [Full Text] [Related]
4. Clinicopathological and prognostic significance of lkb1 expression in gastric cancer: a systematic review and meta-analysis.
Tan G; Liu B
Sci Rep; 2023 Jun; 13(1):8937. PubMed ID: 37264076
[TBL] [Abstract] [Full Text] [Related]
5. DNA methylation-mediated silencing of Neuronatin promotes hepatocellular carcinoma proliferation through the PI3K-Akt signaling pathway.
Deng Y; Lu L; Liang X; Li J; Zhu D; Huang H; Zhang Y; Zhang X; Chen Y; Liu X; Fu Y
Life Sci; 2023 Jan; 312():121266. PubMed ID: 36473542
[TBL] [Abstract] [Full Text] [Related]
6. A subset of VEGFR-TKIs activates AMPK in lkb1-mutant lung cancer.
Yang L; Zhang Q; Xiong Y; Dang Z; Xiao H; Chen Q; Dai X; Zhang L; Zhu J; Wang D; Li M
Cancer Sci; 2023 Apr; 114(4):1651-1662. PubMed ID: 36459496
[TBL] [Abstract] [Full Text] [Related]
7. RNF126 contributes to stem cell-like properties and metastasis in hepatocellular carcinoma through ubiquitination and degradation of lkb1.
Huang J; Li Y; Zheng M; He H; Xu D; Tian D
Hum Cell; 2022 Nov; 35(6):1869-1884. PubMed ID: 36068398
[TBL] [Abstract] [Full Text] [Related]
8. liver kinase B1 in exosomes inhibits immune checkpoint programmed death ligand 1 and metastatic progression of intrahepatic cholangiocarcinoma.
Liu Z; Zhou K; Zeng J; Zhou X; Li H; Peng K; Liu X; Li F; Jiang B; Zhao M; Ma T
Oncol Rep; 2022 Sep; 48(3):. PubMed ID: 35856436
[TBL] [Abstract] [Full Text] [Related]
9. Clinicopathological features and genomic profiles of hepatoid adenocarcinoma of the lung: Report of four cases.
Sun H; Li X; Zhang J; Liu Y
Pathol Res Pract; 2022 Jan; 229():153652. PubMed ID: 34826742
[TBL] [Abstract] [Full Text] [Related]
10. lkb1 expression and the prognosis of lung cancer: A meta-analysis.
Lin C; Lin X; Lin K; Tan J; Wei C; Liu T
Medicine (Baltimore); 2021 Nov; 100(46):e27841. PubMed ID: 34797317
[TBL] [Abstract] [Full Text] [Related]
11. HDAC11 Regulates Glycolysis through the lkb1/AMPK Signaling Pathway to Maintain Hepatocellular Carcinoma Stemness.
Bi L; Ren Y; Feng M; Meng P; Wang Q; Chen W; Jiao Q; Wang Y; Du L; Zhou F; Jiang Y; Chen F; Wang C; Tang B; Wang Y
Cancer Res; 2021 Apr; 81(8):2015-2028. PubMed ID: 33602787
[TBL] [Abstract] [Full Text] [Related]
12. Cigarette smoke-induced lkb1/AMPK pathway deficiency reduces EGFR TKI sensitivity in NSCLC.
Cheng FJ; Chen CH; Tsai WC; Wang BW; Yu MC; Hsia TC; Wei YL; Hsiao YC; Hu DW; Ho CY; Li TS; Wu CY; Chou WY; Yu YL; Tang CH; Chen CY; Chen CM; Hsu JL; Chen HF; Chen Y; Tu CY; Hung MC; Huang WC
Oncogene; 2021 Feb; 40(6):1162-1175. PubMed ID: 33335306
[TBL] [Abstract] [Full Text] [Related]
13. MLH1 single-nucleotide variant in circulating tumor DNA predicts overall survival of patients with hepatocellular carcinoma.
Kim SS; Eun JW; Choi JH; Woo HG; Cho HJ; Ahn HR; Suh CW; Baek GO; Cho SW; Cheong JY
Sci Rep; 2020 Oct; 10(1):17862. PubMed ID: 33082400
[TBL] [Abstract] [Full Text] [Related]
14. Distinct promoter methylation patterns of lkb1 in the hamartomatous polyps of Peutz-Jeghers syndrome and its potential in gastrointestinal malignancy prediction.
Li T; Lin W; Zhao Y; Zhu J; Sun T; Ren L
Orphanet J Rare Dis; 2020 Aug; 15(1):208. PubMed ID: 32799895
[TBL] [Abstract] [Full Text] [Related]
15. lkb1 inhibits intrahepatic cholangiocarcinoma by repressing the transcriptional activity of the immune checkpoint PD-L1.
Liu Z; Li S; Zeng J; Zhou X; Li H; Liu X; Li F; Jiang B; Zhao M; Ma T
Life Sci; 2020 Sep; 257():118068. PubMed ID: 32653521
[TBL] [Abstract] [Full Text] [Related]
16. lkb1/stk11 Expression in Lung Adenocarcinoma and Associations With Patterns of Recurrence.
Mitchell KG; Parra ER; Zhang J; Nelson DB; Corsini EM; Villalobos P; Moran CA; Skoulidis F; Wistuba II; Fujimoto J; Roth JA; Antonoff MB;
Ann Thorac Surg; 2020 Oct; 110(4):1131-1138. PubMed ID: 32442617
[TBL] [Abstract] [Full Text] [Related]
17. Serine threonine kinase 11/liver kinase B1 mutation in sporadic scirrhous-type gastric cancer cells.
Nishimura S; Yashiro M; Sera T; Yamamoto Y; Kushitani Y; Sugimoto A; Kushiyama S; Togano S; Kuroda K; Okuno T; Murakami Y; Ohira M
Carcinogenesis; 2020 Nov; 41(11):1616-1623. PubMed ID: 32236518
[TBL] [Abstract] [Full Text] [Related]
18. Wnt/β-catenin signaling as an emerging potential key pharmacological target in cholangiocarcinoma.
Zhang GF; Qiu L; Yang SL; Wu JC; Liu TJ
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32140709
[TBL] [Abstract] [Full Text] [Related]
19. Rapid progressive lung cancers harbouring multiple clonal driver mutations with big bang evolution model.
Kunimasa K; Hirotsu Y; Nakamura H; Tamiya M; Iijima Y; Ishida H; Hamamoto Y; Maniwa T; Kimura T; Nishino K; Goto T; Amemiya K; Mochizuki H; Oyama T; Nakatsuka SI; Kumagai T; Okami J; Higashiyama M; Imamura F; Omata M
Cancer Genet; 2020 Feb; 241():51-56. PubMed ID: 31917104
[TBL] [Abstract] [Full Text] [Related]
20. Association between lkb1 expression and prognosis of patients with solid tumours: an updated systematic review and meta-analysis.
Ren YH; Zhao FJ; Mo HY; Jia RR; Tang J; Zhao XH; Wei JL; Huo RR; Li QQ; You XM
BMJ Open; 2019 Aug; 9(8):e027185. PubMed ID: 31383697
[TBL] [Abstract] [Full Text] [Related]
[Next]
